Solulink, Inc. announced that Jack Ball has been appointed as the company's Chief Executive Officer. Mr. Ball will lead the company as it commercializes its HybriLink™ technology. http://www.digitaljournal.com/pr/1459993
Mr. Ball brings a solid track record of life sciences leadership with a strong background in commercial operations, and extensive experience in the life science markets. Most recently, he served as Chief Commercial Officer at Accuri Cytometers, Inc., before its acquisition by BD Biosciences in 2011. Prior to joining Accuri, Mr. Ball was CEO of Amnis Corporation, a venture-backed, technology start-up developing high-end imaging flow cytometers. He also served as Chief Commercial Officer for Molecular Probes, Inc. Before that, Mr. Ball was the Senior VP & General Manager of the Life Sciences Group at Orchid Biosciences, and a senior executive at Amersham Pharmacia Biotech Inc.
Solulink, a privately-held life science tools company, develops, manufactures and markets proprietary, next generation linking technology for the development and improvement of products in the research assay and diagnostic markets. Solulink's latest innovation, the HybriLink Technology, improves the capabilities of end users, developers and suppliers to utilize the growing wide variety of detection technologies for research and diagnostic life science assays. Solulink markets their products directly and through distributors and licensing partners world-wide.